drugset / Trial / NCT00304707

Effectiveness of Bupropion for Smokers Recovering From Alcohol Dependence

NCT00304707

Phase 3 Completed 143 enrolled National Institute on Drug Abuse (NIDA)
RandomizedFactorialQuadruple-blindTreatment

Summary

Smoking is often a problem for alcohol dependent individuals. Many people who seek treatment for alcohol dependence are unable to quit smoking. The purpose of this study is to evaluate the effectiveness of bupropion, an antidepressant medication, in treating smokers receiving treatment for alcohol dependence.

Timeline

Start
2005-04
Primary completion
2010-02
Completion
2011-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Bupropion Small molecule 300 mg